Literature DB >> 14760761

Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

Wen-Hua Xiao1, Wei-Wen Liu.   

Abstract

AIM: To analyze the genetic and epigenetic alterations of RUNX3 gene, a potential putative tumor suppressor gene, in hepatocellular carcinoma (HCC).
METHODS: PCR-based loss of heterozygosity (LOH) detection, analysis of mutation with PCR-single strand conformational polymorphism (SSCP) and sequencing, and methylation study with methylation specific PCR (MSP) were performed on RUNX3 gene in a series of 62 HCCs along with their matched normal tissues.
RESULTS: Mutation of RUNX3 gene was not found, but one single nucleotide polymorphism with T to A transversion at the second nucleotide of the 18th codon was found. Nine of 26 informative cases (34.6%) showed allelic loss on the polymorphic site and 30 cases (48.4%) revealed hypermethylation of RUNX3 gene in promoter CpG islands. Furthermore, of the 9 cases with LOH, 8 (88.9%) also had hypermethylation.
CONCLUSION: Our findings indicate that inactivation of RUNX3 gene through allelic loss and promoter hypermethylation might be one of the major mechanisms in hepatocellular carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760761      PMCID: PMC4724901          DOI: 10.3748/wjg.v10.i3.376

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Quantitative analysis of promoter hypermethylation in laser-microdissected archival specimens.

Authors:  U Lehmann; B Hasemeier; R Lilischkis; H Kreipe
Journal:  Lab Invest       Date:  2001-04       Impact factor: 5.662

2.  Cancer. Death and methylation.

Authors:  P A Jones
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

3.  RUNX genes, neoplasia, and cleidocranial dysplasia.

Authors:  M M Cohen
Journal:  Am J Med Genet       Date:  2001-12-01

4.  SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.

Authors:  H Yoshikawa; K Matsubara; G S Qian; P Jackson; J D Groopman; J E Manning; C C Harris; J G Herman
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

Review 5.  Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation.

Authors:  Aristidis Moustakas; Katerina Pardali; Annamaria Gaal; Carl Henrik Heldin
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

6.  Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.

Authors:  M Makos; B D Nelkin; R E Reiter; J R Gnarra; J Brooks; W Isaacs; M Linehan; S B Baylin
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

7.  An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.

Authors:  M Sun; J R Eshleman; L D Ferrell; G Jacobs; E C Sudilovsky; R Tuthill; M R Hussein; O Sudilovsky
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

8.  Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region.

Authors:  W Fang; Z Piao; D Simon; J C Sheu; S Huang
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

9.  Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.

Authors:  P Bedossa; E Peltier; B Terris; D Franco; T Poynard
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

10.  Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.

Authors:  Y Shirai; S Kawata; S Tamura; N Ito; H Tsushima; K Takaishi; S Kiso; Y Matsuzawa
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

View more
  25 in total

Review 1.  Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.

Authors:  Faisal Saeed Khan; Ijaz Ali; Ume Kalsoom Afridi; Muhammad Ishtiaq; Rashid Mehmood
Journal:  Hepatol Int       Date:  2016-06-07       Impact factor: 6.047

2.  The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.

Authors:  Takashi Yano; Kosei Ito; Hiroshi Fukamachi; Xin-Zi Chi; Hee-Jun Wee; Ken-ichi Inoue; Hiroshi Ida; Philippe Bouillet; Andreas Strasser; Suk-Chul Bae; Yoshiaki Ito
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

3.  Rare allelic imbalances, but no mutations of the PRDX1 gene in human hepatocellular carcinomas.

Authors:  J Gisin; A Perren; M Bawohl; W Jochum
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

Authors:  Xin-Zi Chi; Jeung-Ook Yang; Kwang-Youl Lee; Kosei Ito; Chohei Sakakura; Qing-Lin Li; Hye-Ryun Kim; Eun-Jeung Cha; Yong-Hee Lee; Atsushi Kaneda; Toshikazu Ushijima; Wun-Jae Kim; Yoshiaki Ito; Suk-Chul Bae
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration.

Authors:  Peng-Jin Mei; Jin Bai; Hui Liu; Chen Li; Yong-Ping Wu; Zheng-Quan Yu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-16       Impact factor: 4.553

6.  Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age.

Authors:  Jennifer Z J Maccani; Devin C Koestler; Eugene Andrés Houseman; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

7.  The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.

Authors:  Do Youn Park; Hideo Sakamoto; Sandra D Kirley; Shuji Ogino; Takako Kawasaki; Eunjeong Kwon; Mari Mino-Kenudson; Gregory Y Lauwers; Daniel C Chung; Bo R Rueda; Lawrence R Zukerberg
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

Review 8.  Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma.

Authors:  Yuewu Yang; Zhiqiang Ye; Zengcheng Zou; Gemin Xiao; Gangjian Luo; Hongzhi Yang
Journal:  Tumour Biol       Date:  2014-07-19

9.  Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.

Authors:  Feng Gao; Canhua Huang; Mei Lin; Zhi Wang; Jun Shen; Haiyuan Zhang; Lu Jiang; Qianming Chen
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-18       Impact factor: 4.553

10.  Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.

Authors:  Yun-Mi Goh; Senthilkumar Cinghu; Eileen Tan Hwee Hong; You-Soub Lee; Jang-Hyun Kim; Ju-Won Jang; Ying-Hui Li; Xin-Zi Chi; Kyeong-Sook Lee; Heejun Wee; Yoshiaki Ito; Byung-Chul Oh; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.